Elevatus Welath Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Buy
6,070
+558
+10% +$101K 0.22% 94
2026
Q1
$811K Sell
5,512
-781
-12% -$127K 0.43% 53
2025
Q4
$1.23M Buy
6,293
+2
+0% +$476 0.34% 60
2025
Q3
$1.77M Buy
6,291
+310
+5% +$78.9K 0.51% 47
2025
Q2
$1.31M Buy
5,981
+448
+8% +$72.3K 0.44% 42
2025
Q1
$774K Sell
5,533
-16
-0.3% -$2.6K 0.44% 40
2024
Q4
$925K Buy
5,549
+99
+2% +$17.6K 0.32% 38
2024
Q3
$929K Buy
5,450
+203
+4% +$29.4K 0.3% 41
2024
Q2
$741K Buy
5,247
+12
+0.2% +$1.49K 0.28% 59
2024
Q1
$658K Buy
5,235
+187
+4% +$21.4K 0.26% 47
2023
Q4
$532K Buy
5,048
+142
+3% +$15.5K 0.24% 50
2023
Q3
$520K Buy
4,906
+453
+10% +$52.4K 0.47% 37
2023
Q2
$530K Buy
+4,453
New +$460K 0.37% 35

Other funds holding ORCL

Elevatus Welath Management's ORCL Position: Q2 2026 in Review

Elevatus Welath Management increased its Oracle (ORCL) stake by 10% in Q2 2026, buying an estimated $101K and bringing the position to 6,070 shares worth $890K. The position accounts for 0.22% of the portfolio, ranked #94.

Elevatus Welath Management first reported a position in ORCL in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.77M in Q3 2025. 3,528 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Elevatus Welath Management held 6,070 shares of Oracle worth $890K as of Q2 2026.
  • Elevatus Welath Management bought 558 Oracle shares in Q2 2026, an estimated $101K.
  • Oracle made up 0.22% of Elevatus Welath Management's portfolio in Q2 2026, its #94 holding.
  • Elevatus Welath Management first reported a position in Oracle in Q2 2023 and has held it in 13 quarters since.
  • Elevatus Welath Management's Oracle position peaked at $1.77M in Q3 2025.
  • 3,528 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Elevatus Welath Management's 13F filing for Q2 2026, filed 13 Aug 2026.